Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-17ARWR3Initial Statement of Beneficial Ownership of Securities
This filing reports the initial statement of beneficial ownership of securities for Matthew Gregory Cohen, an insider at ARROWHEAD PHARMACEUTICALS, INC. The filing indicates that Mr. Cohen holds 0 shares of Common Stock directly following the transaction. The report was filed on June 17, 2026, pertaining to the period ...
Large CapBiotechnology
2026-06-17ADTX3Ownership Filing by DRW Securities, LLCMEDIUM
This filing reports that DRW Securities, LLC, a 10% owner, now directly owns 126,772 shares of Aditxt, Inc. common stock following a transaction on June 16, 2026. The signature date was June 17, 2026....
Nano CapBiotechnology
2026-06-17BRTX3Katharyn Field Reports No Securities Ownership in BioRestorative Therapies
This Form 3 filing reports that Katharyn Field, a director of BioRestorative Therapies, Inc. (BRTX), has no securities ownership in the company as of June 10, 2026. The filing indicates that Field is a director but not an officer or 10% owner of the company. The document was signed on June 17, 2026, and reports a perio...
Nano CapBiotechnology